These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R. J Diabetes Sci Technol; 2009 Sep 01; 3(5):1109-20. PubMed ID: 20144424 [Abstract] [Full Text] [Related]
5. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes. Thabit H, Elleri D, Leelarathna L, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Barnard KD, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R. Diabetes Obes Metab; 2015 May 01; 17(5):452-8. PubMed ID: 25492378 [Abstract] [Full Text] [Related]
13. Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study. Kumareswaran K, Thabit H, Leelarathna L, Caldwell K, Elleri D, Allen JM, Nodale M, Wilinska ME, Evans ML, Hovorka R. Diabetes Care; 2014 Oct 13; 37(5):1198-203. PubMed ID: 24026542 [Abstract] [Full Text] [Related]
14. Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort. Kumareswaran K, Elleri D, Allen JM, Harris J, Xing D, Kollman C, Nodale M, Murphy HR, Amiel SA, Heller SR, Wilinska ME, Acerini CL, Evans ML, Dunger DB, Hovorka R. J Diabetes Sci Technol; 2011 Nov 01; 5(6):1352-62. PubMed ID: 22226252 [Abstract] [Full Text] [Related]
15. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R. CMAJ; 2013 Mar 05; 185(4):297-305. PubMed ID: 23359039 [Abstract] [Full Text] [Related]
17. Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control. Raz I, Bitton G, Feldman D, Alon T, Pfutzner A, Tamborlane WV. J Diabetes Sci Technol; 2015 May 05; 9(3):639-43. PubMed ID: 25883166 [Abstract] [Full Text] [Related]
18. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. Bally L, Thabit H, Tauschmann M, Allen JM, Hartnell S, Wilinska ME, Exall J, Huegel V, Sibayan J, Borgman S, Cheng P, Blackburn M, Lawton J, Elleri D, Leelarathna L, Acerini CL, Campbell F, Shah VN, Criego A, Evans ML, Dunger DB, Kollman C, Bergenstal RM, Hovorka R. BMJ Open; 2017 Jul 13; 7(7):e016738. PubMed ID: 28710224 [Abstract] [Full Text] [Related]
19. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Attia N, Jones TW, Holcombe J, Tamborlane WV. Diabetes Care; 1998 May 13; 21(5):817-21. PubMed ID: 9589247 [Abstract] [Full Text] [Related]
20. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, Battelino T, Danne T, Weinzimer SA, Sibayan J, Johnson ML, Bailey RJ, Calhoun P, Carlson A, Isganaitis E, Bello R, Albanese-O'Neill A, Dovc K, Biester T, Weyman K, Hood K, Phillip M, FLAIR Study Group. Lancet; 2021 Jan 16; 397(10270):208-219. PubMed ID: 33453783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]